Comparison of 0.1% Bromfenac Sodium and 0.1% Pemirolast Potassium for the Treatment of Allergic Conjunctivitis

@article{MiyakeKashima2004ComparisonO0,
  title={Comparison of 0.1% Bromfenac Sodium and 0.1% Pemirolast Potassium for the Treatment of Allergic Conjunctivitis},
  author={Minori Miyake-Kashima and Yoji Takano and Mari Tanaka and Yoshiyuki Satake and Tetsuya Kawakita and Murat Doğru and Naoko Asano-Kato and Kazumi Fukagawa and Hiroshi Fujishima},
  journal={Japanese Journal of Ophthalmology},
  year={2004},
  volume={48},
  pages={587-590}
}
We compared the efficacy of a new nonsteroidal antiinflammatory drug (NSAID) eye drop, 0.1% bromfenac sodium (Bromfenac), with that of an antiallergic agent, 0.1% pemirolast potassium (Pemirolast), in the treatment of seasonal allergic conjunctivitis in Japanese patients. Twenty-two subjects with seasonal allergic conjunctivitis were enrolled in the study. One eye was treated with Bromfenac eye drops and the contralateral eye was treated with Pemirolast eye drops for 1 week. Subjective ocular… CONTINUE READING